These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18070217)

  • 1. In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.
    Okamura N; Funaki Y; Tashiro M; Kato M; Ishikawa Y; Maruyama M; Ishikawa H; Meguro K; Iwata R; Yanai K
    Br J Clin Pharmacol; 2008 Apr; 65(4):472-9. PubMed ID: 18070217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.
    Kuhl DE; Minoshima S; Frey KA; Foster NL; Kilbourn MR; Koeppe RA
    Ann Neurol; 2000 Sep; 48(3):391-5. PubMed ID: 10976649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-(11)C-methoxy]donepezil.
    Hiraoka K; Okamura N; Funaki Y; Watanuki S; Tashiro M; Kato M; Hayashi A; Hosokai Y; Yamasaki H; Fujii T; Mori E; Yanai K; Watabe H
    Neuroimage; 2009 Jul; 46(3):616-23. PubMed ID: 19286462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal rat.
    Watabe T; Naka S; Ikeda H; Horitsugi G; Kanai Y; Isohashi K; Ishibashi M; Kato H; Shimosegawa E; Watabe H; Hatazawa J
    PLoS One; 2014; 9(9):e107427. PubMed ID: 25225806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography.
    Ota T; Shinotoh H; Fukushi K; Kikuchi T; Sato K; Tanaka N; Shimada H; Hirano S; Miyoshi M; Arai H; Suhara T; Irie T
    Clin Neuropharmacol; 2010; 33(2):74-8. PubMed ID: 19935404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
    Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
    Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
    Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
    Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase.
    Funaki Y; Kato M; Iwata R; Sakurai E; Sakurai E; Tashiro M; Ido T; Yanai K
    J Pharmacol Sci; 2003 Feb; 91(2):105-12. PubMed ID: 12686754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.
    Shinotoh H; Aotsuka A; Fukushi K; Nagatsuka S; Tanaka N; Ota T; Tanada S; Irie T
    Neurology; 2001 Feb; 56(3):408-10. PubMed ID: 11171913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.
    Bohnen NI; Kaufer DI; Hendrickson R; Ivanco LS; Lopresti BJ; Koeppe RA; Meltzer CC; Constantine G; Davis JG; Mathis CA; Dekosky ST; Moore RY
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):315-9. PubMed ID: 15716518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
    Doody RS; Corey-Bloom J; Zhang R; Li H; Ieni J; Schindler R
    Drugs Aging; 2008; 25(2):163-74. PubMed ID: 18257603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging.
    Kimura H; Kawai T; Hamashima Y; Kawashima H; Miura K; Nakaya Y; Hirasawa M; Arimitsu K; Kajimoto T; Ohmomo Y; Ono M; Node M; Saji H
    Bioorg Med Chem; 2014 Jan; 22(1):285-91. PubMed ID: 24315193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study.
    Kasuya M; Meguro K; Okamura N; Funaki Y; Ishikawa H; Tanaka N; Iwata R; Yanai K
    Alzheimer Dis Assoc Disord; 2012; 26(2):113-8. PubMed ID: 21666432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
    Gjerløff T; Fedorova T; Knudsen K; Munk OL; Nahimi A; Jacobsen S; Danielsen EH; Terkelsen AJ; Hansen J; Pavese N; Brooks DJ; Borghammer P
    Brain; 2015 Mar; 138(Pt 3):653-63. PubMed ID: 25539902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.